Search

Your search keyword '"Gemicioglu, B."' showing total 228 results

Search Constraints

Start Over You searched for: Author "Gemicioglu, B." Remove constraint Author: "Gemicioglu, B."
228 results on '"Gemicioglu, B."'

Search Results

1. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

2. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

3. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study

4. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

5. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries

6. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

7. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

8. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

9. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

10. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

11. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

12. The ARIA-MeDALL hypothesis

13. Discrepancies between anti-Intereukin5 (anti-IL5) starters from SHARP central registry and eligible patients in clinical trials

14. Mepolizumab effectiveness in severe asthma supported by federated analysis of European SHARP data

16. Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

17. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

18. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

19. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app.

20. Development and validation of combined symptom-medication scores for allergic rhinitis*

21. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

22. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

23. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

25. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

26. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

28. Pregnancy Outcomes of the Asthma Patients on Omalizumab in Turkey

29. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

30. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

31. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

33. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

34. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

35. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

37. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

38. Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): Focus presentations at the 11th GARD General Meeting, Brussels

39. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

40. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

41. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

42. Daily allergic multimorbidity in rhinitis using mobile technology : A novel concept of the MASK study

43. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study.

44. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

45. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

46. The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life:The MASK study

47. Asthma phenotypes in Turkey: a multicenter cross-sectional study in adult asthmatics; PHENOTURK study

48. Asthma phenotypes in Turkey: a multicenter cross-sectional study in adult asthmatics; PHENOTURK study

49. ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

50. Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study

Catalog

Books, media, physical & digital resources